The articles discussing the use of AI in glioma were classified into detection, grading, prediction of the IDH genotype, MGMT promoter methylation status (which is a mutation associated with an improved prognosis), 1p19q codeletion, survival prediction, treatment response, pseudo-progression and progression and the glioma functional network. The gene discussed is MGMT; the disease is central nervous system cancer.